Metastatic secondary fibrosarcoma of bone responsive to repeated courses of Ifosfamide and associated with hypoglycemia.

about

Metastatic secondary fibrosarcoma of bone responsive to repeated courses of Ifosfamide and associated with hypoglycemia.

Item

http://www.wikidata.org/entity/Q38613398

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Metastatic secondary fibrosarc ...... associated with hypoglycemia.

@en

type

Item

label

Metastatic secondary fibrosarc ...... associated with hypoglycemia.

@en

prefLabel

Metastatic secondary fibrosarc ...... associated with hypoglycemia.

@en

P1476

Metastatic secondary fibrosarc ...... associated with hypoglycemia.

@en

P2093

Elaine S Bouttell

http://www.w3.org/2001/XMLSchema#string

N Wilson Rodger

http://www.w3.org/2001/XMLSchema#string

Vivien H C Bramwell

http://www.w3.org/2001/XMLSchema#string

P2860

FIBRO-SARCOMA OF THE MEDIASTINUM

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors.

Soft tissue fibrosarcoma. A clinicopathologic study of 132 cases.

Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia?

Doxorubicin-based chemotherapy for the palliative treatment of adult patients with locally advanced or metastatic soft-tissue sarcoma: a meta-analysis and clinical practice guideline.

Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients.

Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia.

Biological and immunological properties of insulin-like growth factors (IGF) I and II.

Results of single-agent and combination chemotherapy for advanced soft tissue sarcomas. Implications for decision making in the clinic.

P304

81-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13577140310001607329

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51397820

http://www.w3.org/2001/XMLSchema#string

P698

18521374

http://www.w3.org/2001/XMLSchema#string

P921

hypoglycemia

P932

2395515

http://www.w3.org/2001/XMLSchema#string